Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04342663
Brief Title: A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection (STOP COVID)

First Submitted : April 8, 2020
First Submitted that Met QC Criteria : April 8, 2020
First Posted : April 13, 2020

Results First Submitted : July 1, 2021
Results First Posted with QC Comments : July 8, 2021
Results First Submitted that Met QC Criteria : July 7, 2021
Results First Posted : July 9, 2021

Last Update Submitted that Met QC Criteria : July 7, 2021
Last Update Posted : July 9, 2021